| Titel: | MRD registry and multicenter, two-arm, randomized controlled pragmatic trial of standard intensity versus reduced intensity consolidation treatment in MRD-negative patients with AML or CLL (RESOLVE trial) |
| Kurzbezeichnung: | OSHO#104 RESOLVEHORIZON-MISS-2023-CANCER-01-03 Project-ID: 101136502 |
| Studienleitung/-zentrale: | Hannover Medical School (MHH) Prof. Dr. med. Michael Heuser Clinic for Hematology, Hemostaseology, Oncology and Stem Cell Transplantation Carl-Neuberg-Straße 1 30625 Hannover E-Mail: coordination.resolve@mh-hannover.de |
| Studiendesign: | The MRD registry is an observational registry in which AML and CLL patients are registered if they are potentially eligible for randomization in the RESOLVE trial. |
| Rekrutierungszeitraum: | aktiv |
